Tech Company Financing Transactions

Antares Therapeutics Funding Round

Atlas Venture, BVF Partners and Cormorant Asset Management participated in a $177 million Series A funding round for Antares Therapeutics. The financing was announced on 6/11/2025.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1 Winthrop Square 400
Boston, MA 02110
USA

Phone

Undisclosed

Website

www.antaresrx.com

Email Address

Not Recorded

Overview

Accelerated by the discovery capabilities and validated pipeline built at Scorpion Therapeutics (acquired by Lilly in March 2025), Antares pushes scientific boundaries and challenges assumptions to unlock new possibilities for improving patients' lives.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Adam Friedman

        

Browse more venture capital transactions:

Prev: 6/11/2025: Outset venture capital transaction
Next: 6/11/2025: SpliceBio venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary